Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms

STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more

Paul Hastings Advises Bank of America and Morgan Stanley on $4.5 Billion Committed Bridge Financing for Vertex’s $10 Billion Acquisition of Crinetics

STAT+: Compass says depression drug has long-lasting benefits

GSK in talks to acquire Nuvalent for over $9 billion in largest deal in more than a decade

GSK is in talks to acquire biotech firm Nuvalent for more than $9 billion, which would be its largest acquisition in over a decade and the s

Stocks making the biggest moves premarket: Fiserv, Crinetics Pharmaceuticals, Micron & more